{"slideshow_credits": null, "snippet": "Amgen disputes that it lobbied Congress for extension of a patent.", "abstract": null, "section_name": "Opinion", "print_page": "", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2013/02/04/opinion/the-drug-maker-amgen-objects.html", "lead_paragraph": "Amgen disputes that it lobbied Congress for extension of a patent.", "headline": {"seo": "The Drug Maker Amgen Objects", "main": "A Drug Maker Objects", "print_headline": "A Drug Maker Objects", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "510f2e0700315214fbb88f12", "word_count": "161", "multimedia": [], "pub_date": "2013-02-04T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Amgen Inc", "name": "organizations", "is_major": "N", "rank": "1"}, {"value": "Senate", "name": "organizations", "is_major": "N", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Lobbying and Lobbyists", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}